Shire plc Director Declaration

TIDMSHP 
 
   Director Declaration 
 
   December 21, 2018 - Shire plc (LSE: SHP, NASDAQ: SHPG) (the "Company") 
announces that Ian Clark, Non-Executive Director of the Company, is a 
Non-Executive Director of Guardant Health, Inc which became publically 
quoted on October 4, 2018. 
 
   This disclosure is made pursuant to LR 9.6.14 of the UK Listing Rules. 
 
   Sarah Rixon 
 
   Senior Company Secretarial Assistant 
 
   For further information please contact: 
 
 
 
 
Investor Relations 
Christoph Brackmann   [e-mail]   [phone] 
Sun Kim               [e-mail]                [phone] 
Scott Burrows         [e-mail]          [phone] 
Media 
Katie Joyce           [e-mail]                 [phone] 
 
 
   NOTES TO EDITORS 
 
   About Shire 
 
   Shire is the global biotechnology leader serving patients with rare 
diseases and specialized conditions. We seek to push boundaries through 
discovering and delivering new possibilities for patient communities who 
often have few or no other champions. Relentlessly on the edge of what's 
next, we are serial innovators with a diverse pipeline offering fresh 
thinking and new hope. Serving patients and partnering with healthcare 
communities in over 100 countries, we strive to be part of the entire 
patient journey to enable earlier diagnosis, raise standards of care, 
accelerate access to treatment, and support patients. Our diverse 
portfolio of therapeutic areas includes Immunology, Hematology, Genetic 
Diseases, Neuroscience, Internal Medicine, and Ophthalmics. 
 
 
 
   Championing patients is our call to action - it brings the opportunity - 
and responsibility - to change people's lives. 
 
   www.shire.com 
 
 
 
 

(END) Dow Jones Newswires

December 21, 2018 11:15 ET (16:15 GMT)

Copyright (c) 2018 Dow Jones & Company, Inc.